- 专利标题： Method and devices for determining a treatment regimen for altering the treatment parameters when dialyzing a patient
-
申请号： US16956281申请日： 2018-12-17
-
公开(公告)号： US11786644B2公开(公告)日： 2023-10-17
- 发明人: Andreas Maierhofer
- 申请人： Fresenius Medical Care Deutschland GmbH
- 申请人地址： DE Bad Homburg
- 专利权人： Fresenius Medical Care Deutschland GmbH
- 当前专利权人： Fresenius Medical Care Deutschland GmbH
- 当前专利权人地址： DE Bad Homburg
- 代理机构： Fish & Richardson P.C.
- 优先权： DE 2017130548.3 2017.12.19
- 国际申请： PCT/EP2018/085222 2018.12.17
- 国际公布： WO2019/121523A 2019.06.27
- 进入国家日期： 2020-06-19
- 主分类号： A61M1/16
- IPC分类号： A61M1/16 ; A61M1/34 ; G16H20/40 ; G16H50/50 ; G16H50/30 ; G16H50/20 ; G16H40/40 ; G16H40/63 ; G05B6/02
摘要：
A method for determining a treatment regimen for altering the treatment parameters when dialyzing a patient over a plurality of treatment sessions taking place on future days includes determining a diffusive total target sodium balance; and determining a transitional treatment regimen by which the diffusive total target sodium balance is achieved over the plurality of future treatment sessions. A control device or closed-loop control device is configured to control a blood treatment apparatus using the method.
公开/授权文献
信息查询
IPC分类:
